According to the latest report by IMARC Group, titled, “Microbiome Sequencing Services Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028“, Offers a comprehensive analysis of the industry, which comprises insights on the microbiome sequencing services market growth. The global microbiome sequencing services market size reached US$ 1,846.3 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 5,568.4 Million by 2028, exhibiting a growth rate (CAGR) of 20% during 2023-2028.
Microbiome sequencing services comprise various sequencing, such as rRNA, shotgun metagenomics, whole genome, and targeted gene sequencing. They utilize next-generation sequencing (NGS) instruments to generate real insights of microbe in the body. They assist in identifying the function of the microbiome in human health and disease pathogenesis. As they offer fast, accurate, and highly reliable results as compared to traditional methods, microbiome sequencing services are widely utilized in pharmaceutical and biotechnology industries across the globe.
Get a PDF Sample for more detailed market insights: https://www.imarcgroup.com/microbiome-sequencing-services-market/requestsample
Microbiome Sequencing Services Market Trends and Drivers:
At present, the rising human microbiome therapies to treat and detect numerous diseases among individuals around the world represents one of the key factors contributing to the market growth. Besides this, the growing number of students in research and development (R&D) institutes in the genomics field across the globe is offering a positive market outlook. Apart from this, the increasing awareness among the masses about the benefits of microbiome sequencing for cancer treatment is positively influencing the market. Moreover, the rising demand for microbiome sequencing services among individuals to identify early disease detection and diagnosis is bolstering the growth of the market. Furthermore, the rising healthcare expenditure, along with the increasing government investment in next-generation sequencing (NGS) across the globe, is strengthening the growth of the market.
Microbiome Sequencing Services Market 2023-2028 Competitive Analysis and Segmentation:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
- BaseClear B.V.
- Clinical-Microbiomics A/S
- Diversigen Inc (OraSure Technologies Inc.)
- Mérieux NutriSciences
- Metabiomics Corporation (BioSpherex LLC)
- Microbiome Insights Inc.
- Microbiome Therapeutics LLC
- Molecular Research LP
- Molzym GmbH & Co. KG
- Resphera Biosciences LLC
- Shanghai Realbio Technology (RBT) Co. Ltd.
- Zymo Research Corporation.
The report has segmented the market based on technology, research type, laboratory type, application and end user.
Breakup by Technology:
- Sequencing by Synthesis (SBS)
- Sequencing by Ligation (SBL)
- Sanger Sequencing
Breakup by Research Type:
- Outsourced Research
- Internal Research
Breakup by Laboratory Type:
- Dry Labs
- Wet Labs
Breakup by Application:
- Shotgun Sequencing
- Targeted Gene Sequencing
- RNA Sequencing
- Whole Genome Sequencing
Breakup by End User:
- Pharmaceutical and Biotechnology Companies
- Research and Academic Institutes
Breakup by Region:
- North America
- Latin America
- Middle East and Africa
Ask Analyst for 10% Free Customized Report: https://www.imarcgroup.com/request?type=report&id=4357&flag=C
Key highlights of the report:
- Market Performance (2017-2022)
- Market Outlook (2023-2028)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Follow us on Twitter: @imarcglobal